Are inhaled corticosteroids associated with an increased risk of fracture in children?
Inhaled corticosteroids are widely used in the long-term management of asthma in children. Data on the relationship between inhaled corticosteroid therapy and osteoporotic fracture are inconsistent. We address this issue in a large population-based cohort of children aged 4–17 years in the UK (the General Practice Research Database). The incidence rates of fracture among children aged 4–17 years taking inhaled corticosteroids (n=97,387), taking bronchodilators only (n=70 984) and a reference group (n=345,758) were estimated. Each child with a non-vertebral fracture (n=23,984) was subsequently matched by age, sex, practice, and calendar time to one child without a fracture. Fracture incidence was increased in children using inhaled corticosteroids, as well as in those receiving bronchodilators alone. With an average daily beclomethasone dose of 200 μg or less, the crude fracture risk relative to nonusers was 1.10 [95% confidence interval (CI), 0.96–1.26]; with dosage of 201–400 μg, it was 1.23 (95% CI, 1.08–1.39); and with dosages over 400 μg, it was 1.36 (95% CI, 1.11–1.67). This excess risk disappeared after adjustment for indicators of asthma severity. The increased risk of fracture associated with use of inhaled corticosteroids is likely to be the result of the underlying illness, rather than being directly attributable to inhaled corticosteroid therapy.
KeywordsAsthma Children Epidemiology Osteoporosis
- 1.British Thoracic Society (1997) The British guidelines on asthma management: 1997 review and position statement. Thorax 52:S1–S21Google Scholar
- 4.Hopp RJ, Degan JA, Biven RE, Kinberg K, Gallagher GC (1995) Longitudinal assessment of bone mineral density in children with chronic asthma. Ann Allergy 75:143–148Google Scholar
- 20.van Staa TP, Abenhaim L (1994) The quality of information recorded on a UK database of primary care records: a study of hospitalization due to hypoglycemia and other conditions. Pharmacoepidemiol Drug Saf 3:15–21Google Scholar
- 22.British Medical Association and the Royal Pharmaceutical Society of Great Britain (1998) British National Formulary Number 36 (September). Pharmaceutical Press, Wallingford, UKGoogle Scholar
- 23.Breslow NE, Day NE (1987) Statistical methods in cancer research. International Agency for Research on Cancer, LyonGoogle Scholar
- 25.Goulding A, Cannan R, Williams SM, Gold EJ, Taylor RW, Lewis-Barned NJ (1998) Bone mineral density in girls with forearm fractures. J Bone Miner Res 13:143–148Google Scholar
- 29.Nordstrom P, Pettersson U, Lorentzon R (1998) Type of physical activity, muscle strength, and pubertal stage as determinants of bone mineral density and bone area in adolescent boys. J Bone Miner Res 13:1141–1148Google Scholar
- 39.Jones A, Fay JK, Burr M, Stone M, Hood K, Roberts G (2003) Inhaled corticosteroid effects on bone metabolism in asthma and mild chronic obstructive pulmonary disease (Cochrane Review). The Cochrane Library, Issue 3. Update Software, OxfordGoogle Scholar
- 40.Richy F, Bousquet J, Ehrlich GE, Meunier PJ, Israel E, Morii H, Devogelaer J-P, Peel N, Haim M, Bruyere O, Reginster J-Y. Inhaled corticosteroids effects on bone in asthmatic and COPD patients: a quantitative systematic review. Osteoporos Int 2003;14:179–190Google Scholar